Results: The Stanford patients with BD were significantly younger at disease onset, had a higher proportion of females, and had longer disease duration than Iranian patients with BD. Genital ulcers, skin, joint, neurological, vascular, cardiopulmonary manifestations were all significantly more common in the Stanford cohort and 38% of Stanford patients had four or more organ systems involved compared with approximately 10% of Iranian patients. In contrast, Stanford patients had fewer ocular lesions (Stanford 21.4% vs. Iran 53.4% p<0.05), with the biggest difference seen for retinal vasculitis. Conclusion: Patients with BD from the Western US have a more severe disease course when compared to Iranian patients with BD, as demonstrated by earlier onset and a higher rate of multi-organ involvement. The high risk of Iranian patients with BD developing vasculitis of ocular structures suggests distinct pathomechanisms driving ocular versus extra-ocular BD.
Introduction
Behçet's disease (BD) is a complex systemic disease, which is classified as a vasculitis, and like other vasculitic syndromes is associated with increased morbidity and mortality (1) (2) (3) . BD typically causes oral and genital ulcerations along with eye manifestations; however, it may affect a range of different organ systems requiring different pharmacological interventions and a multidisciplinary approach (3) (4) (5) . Early diagnosis is considered important to prevent irreversible organ damage (6, 7) . Hurdles to diagnosing BD include its heterogenous presentation, the lack of a pathognomonic diagnostic test, and its low prevalence in Western Europe and North America (8, 9) . Although the diagnosis of BD is made on clinical grounds, several classification criteria exist, which may aid in the diagnosis, with the two most commonly used being the International Study Group (ISG) criteria, and the International Criteria for Bechet's Disease (ICBD) criteria (10, 11) . BD has been reported worldwide, but there are considerable geographical differences in both prevalence rates and disease presentation. BD is most common in countries along the Silk Road, with high rates found in Turkey (80-420/100,000), Iran (80-100/100,000), and Japan (2, 3, 12, 13) . In the United States (US), BD is considered a rare disease, with one study from Olmsted County, Minnesota, reporting an overall incidence rate of 0.38 and a point prevalence rate of 5.2 per 100,000 (14) . Studies comparing cohorts of patients between countries give insights into the presentation and heterogeneity of the disease in different populations. Despite the lower incidence of BD in the US, some studies reported a higher than expected prevalence of central nervous system (CNS) and gastrointestinal (GI) manifestations compared with other endemic regions (15, 16) . There are few or no studies from the US reporting prevalence of pulmonary and cardiac manifestations and frequency of constitutional symptoms (15) .
In the current study, we compare the clinical features of patients with BD from a tertiary referral center located on the West Coast of the US with those from a tertiary referral center in Iran. We also review the 
Methods
This was a retrospective comparative cohort study where patients with a diagnosis of BD and evaluated at Stanford University Hospital were compared with a sample of Iranian patients with BD recruited from the BD registry established at Tehran University of Medical Sciences.
Medical records were reviewed for all Stanford patients (age≥18 y) that fulfilled the International Classification of Diseases, Ninth Revision (ICD-9) diagnostic code of BD (ICD-9: 136.1). The study period spanned from January 1, 2000 to December 31, 2016. The diagnosis of BD was made based on clinical manifestations by experienced treating specialists (rheumatologists, dermatologists, ophthalmologists, and internists), and the diagnosis of BD was confirmed by the expertise of the reviewing rheumatologists for final inclusion into the cohort of patients with BD. We also reviewed the medical records of a representative sample of Iranian patients with BD, recruited from the BD registry at the Shariati Hospital, Rheumatology Research Center (RRC), Tehran University of Medical Sciences. Iranian patients were selected by the stratified randomization method (with the follow-up time as the main covariate) among patients that had their first visit during the same time period (between years 2000 and 2016). Both hospitals function as tertiary referral medical centers.
All demographic, clinical, laboratory, and treatment data were collected. Demographic information included: gender, age at onset of the first BD symptoms, race/ethnicity, date of disease onset, diagnosis, first and last visits, and family history of BD. Clinical characteristics included the presenting manifestation, the presence of oral aphthosis, genital ulcers (GU), skin lesions (pseudofolliculitis/acneiform lesions, erythema nodosum, or other lesions), ocular involvement (uveitis, retinal vasculitis), constitutional signs and symptoms (fatigue, fever, weight loss, malaise), joint manifestations (arthralgia, arthritis, inflammatory back pain), vascular involvement (superficial and deep venous thrombosis, arterial aneurysm and thrombosis), headache, neurological manifestations, including CNS involvement (parenchymal, vascular, meningoencephalitis) and peripheral nervous system, GI involvement, epididymitis, pulmonary, and cardiac involvement. Laboratory tests included pathergy test, erythrocyte sedimentation rate (ESR), C-reactive protein, urinalysis, and the presence of HLA-B5/51 and HLA-B27. All the medications prescribed during the disease course were recorded.
Descriptive statistics, including mean (±stan-dard deviation), numbers or percentages, were calculated to describe the data. The two cohorts were compared using either independent t-tests for continuous ( There were several striking differences seen in the accumulative disease manifestations in the two cohorts ( (Table 3) .
Gastrointestinal involvement was nearly seven times more frequent in Stanford patients with BD (Stanford 26.8% vs. Iran 1.8% p<0.00001). Subgroup analyses showed significant differences for all GI conditions, including terminal ileitis, colitis, rectal bleeding, and "other GI lesions. " There was significantly greater pulmonary involvement (fibrosis, emboli, and pulmonary artery aneurysm) in Stanford patients (10.7%) compared with the Iranian ones (0% p=0.001). Similarly, there was significantly greater cardiac involvement in Stanford patients (7.1%) compared with Iranian patients (<1% p=0.016). No difference was seen for epididymo-orchitis, renal involvement, or presence of hematuria/proteinuria (Table 3 and  Supplementary Table S1 ).
Similar rates (approximately 42%-45%) of patients had increased ESR (Supplementary Table  S1 ). There were no significant differences in the proportion of patients with a positive pathergy test or positive testing for HLA-B5/51 alleles (Table 1) . However, the pathergy test and HLA-B5/51 genotyping had only been performed in 23 (41%) and 17 (30%) of the Stanford BD cohort. With regards to treatment, the two most frequently prescribed drugs in both cohorts were prednisolone and colchicine. Prednisolone was prescribed significantly more often in Stanford patients ( There were marked differences between organ manifestations between the Iranian and Stanford BD cohorts, with higher frequencies for skin, joint, GI, CNS, and vascular manifestations in the Stanford BD cohort (Figure 1a ). Only ocular manifestations were more frequent in the Iranian cohort. Overall, Stanford patients had a higher burden of disease reflected by a higher number of organ systems affected by the vasculitis. A total of 38% of Stanford patients had disease manifestations in four or more organ systems, while approximately only 10% of the Iranian patients had a multi-organ involvement pattern ( Figure 1b ).
As the two BD cohorts had different gender ratios, explorative analyses were performed to investigate whether disease manifestations were associated with gender. In the Iranian BD cohort, ocular and skin manifestations occurred more frequently in male patients (p=0.03, p=0.003), while in the American BD cohort, GU were more common in women (p=0.007). However, the rate of GU in American men was comparable to Iranians of both genders, thus the significant difference between Iranian and American patients was primarily due to the high rates of GU in Stanford women. Interestingly, with regards to vascular events, male patients were twice as often affected as women in both the Iranian (6% vs. 3%) and American cohorts (41% vs. 21%), though these differences were not statistically significant.
We compared the Stanford cohort with four other American BD cohorts from New York University Hospital (NYU I n=634), Michigan 
Discussion
Our findings indicate that American patients with BD have more severe disease than Iranian patients as demonstrated by higher prevalence of disease manifestations in the Stanford BD cohort. The differences were marked, with considerably higher rates seen for almost all organ systems, including the vascular tree, the CNS, the GI tract, and the cardiopulmonary system. Almost 40% of the Stanford patients had four or more organ systems affected, whereas multi-organ disease appeared to be the exception in Iranian patients with BD (10%). The rule of more aggressive disease in the American patients did not extend to the eye; ocular BD occurred in every second Iran patient, but only in one of five American patients, consistent with the concept that pathomechanisms in ocular and non-ocular BD can diverge.
Although there are no previous studies comparing American patients with BD with Iranian ones, there are several studies, which point toward higher prevalence of organ manifestations in American patients with BD, especially for GI and CNS manifestations (15, 16 Other GI manifestations: pancreatitis, eosinophilic esophagitis, gastroparesis/malabsorption, idiopathic gastroparesis, and intestinal obstruction. Pulmonary involvement; embolism (n=3), fibrosis (n=2), and pulmonary artery aneurysm (n=1). Epididymo-orchitis: only present in male patients; Renal: 1 case of interstitial nephritis; Pulmonary involvement: embolism (n=3), fibrosis (n=2), and pulmonary artery aneurysm; Cardiac: pericarditis (n=0), ischemic heart disease (n=4), valvular disease (n=1), cardiomyopathy (n=1), and ventricular aneurysm (n=1).
to classify disease manifestations (18) . For BD, typical gastrointestinal lesions are oval shaped ulcers in the GI tract often found in the terminal ileum, but possibly affecting the whole GI tract (19) (20) (21) . We considered terminal ileitis, colitis, rectal bleeding, and other GI manifestations (pancreatitis, eosinophilic esophagitis, gastroparesis/malabsorption, idiopathic gastroparesis, and intestinal obstruction) as evidence of GI involvement. All diagnoses of colitis and ileitis were verified by endoscopy. We excluded diarrhea, peptic ulcer disease/gastroesophageal reflux disease, and nonspecific dyspepsia as these symptoms are unspecific with other potential etiology. Thus, it is possible that we have under or overestimated GI manifestations attributable to BD. Still, the rates of GI manifestations in the Stanford cohort were comparable to rates seen in other American cohorts, as well as in Japan and Italy (12, 14, 15) .
Vascular manifestations in BD are associated with increased mortality, and arterial aneurysms are one of the most feared complications (7). The rates of vascular manifestations worldwide vary greatly (7%-43%), and accordingly, we found considerably higher rates in the Stanford cohort than in the Iranian cohort (12, 22) . The biggest differences between the two cohorts were seen for arterial aneurysms and thrombosis in large veins, exclusive of DVT. Moreover, vascular CNS manifestations were only encountered in American patients, while other CNS lesions were numerically, but not statistically, different. Interestingly, for retinal vasculitis, which involves part of the CNS, the relationship was reversed, with considerably higher rates seen in Iranian patients than American patients. Retinal vasculitis is a quintessential small-vessel vasculitis, and these results may indicate that BD affects medium to large vessels in the American population and small vessels in the Iranian population. Though BD can manifest in both arteries and veins, we found venous involvement to be more common, which is in accordance to previous reports (4, 22) .The rates of superficial phlebitis, DVT, and pulmonary aneurysms in the Stanford cohort were comparable to those seen in cohorts from NYU and Michigan (15, 17) .
Pulmonary manifestations, which are considered rare in BD, were present in nearly 10% of the Stanford cohort while undetected in the Iranian cohort (23) . There is very limited data on pulmonary manifestations in other American cohorts, except for the NYU cohort, where rates were distinctly low (0.5%) (15) . Of the five American patients with pulmonary manifestations, only one had a pulmonary artery aneurysm while the other four had fibrosis or pulmonary embolism. One could question whether fibrosis and PE represent true BD-associated manifestations. Considering the limited literature and the wide spectrum of this vasculitis, we included these patients in the analyses.
An intriguing difference between the American and Iranian BD cohorts is the difference in gender composition. BD is known to be more common in men in Turkey and the Middle East/Western Asia, while in Korea and Japan the rates are similar between genders, and in Spain/UK it is more common in women (12, 24) . One might hypothesize that the disease etiology differs between populations, affecting men and women at different rates, while giving rise to a similar overall phenotype. Gender has also been shown to be associated with particular disease manifestations, and we find American women are more often affected with GU, which is in accordance to previous studies (25) .
Eye manifestations, typically retinal vasculitis and/or nongranulomatous panuveitis, are associated with high morbidity and mortality, and typically occur in men (1, (25) (26) (27) . Frequencies have been reported to be as high as 50%-70% of patients with BD, with 23% of patients developing poor visual acuity (28) . In the current study, the rate of ocular manifestations was 53% in the Iranian cohort and 21% in the Stanford cohort, and a gender difference (male>female) was seen in the Iranian cohort only. Although the rates of ocular BD were slightly lower (21%) in the Stanford cohort in comparison to the other American cohorts (27%-42%), the rates of ocular manifestations in American BD cohorts are generally lower than those reported for other geographic regions; specifically Iran, Turkey, and Japan (15) (16) (17) 29) . A study from Germany found that German patients of Turkish descent had higher rates of ocular disease than patients of German descent, which may indicate divergent disease pathways in genetically distinct populations (30) . Interestingly, posterior uveitis, which involves part of the CNS (the retina and optic nerve), was more common in Iranian patients, despite all other CNS manifestations being markedly more common in Stanford patients. vere cases, as HLA-B5/51 has been associated to severity (31) . Still, as there was only a limited number of Stanford patients who were tested, there may have been selection bias in which patients were tested. Moreover, studies have shown that pathergy test readings may be affected by needle sharpness and sterilization routines (32) . Interestingly, we did observe a younger age at onset in the Stanford cohort than other US studies. Previous studies have suggested that age at onset may be associated with a more severe course and higher mortality, which could support the high rates of disease manifestations seen in the present study (33, 34) . Furthermore, one could hypothesize whether genetic factors play a greater role in patients with early onset, resulting in a more severe phenotype. We do not consider difference in disease duration a likely explanation for differences in prevalence of clinical features between Iran and Stanford, as the disease duration spanned an extended period for both cohorts.
In the current study, we report for the first time rates of constitutional symptoms in an American BD cohort. We found high rates of fatigue with more than 40% of patients affected. Fatigue is a common symptom in many rheumatological diseases, such as rheumatoid arthritis (RA), but there is limited literature on fatigue in BD (35) (36) (37) . Interestingly, one study found that patients with BD had more fatigue and functional disability than patients with RA (35) . Moreover, in a cross-sectional study by Ilhan et al. (37) disease activity in BD, as well as major organ involvement, were associated with higher fatigue scores. This association could support the findings in the Stanford cohort, where both major organ involvement and fatigue were common.
Taken together, in this retrospective cohort study, we found that American patients with BD are younger, more often female, and have a more severe disease course than those from Iran, where the disease is more common. An interesting discrepancy emerges in the disease patterns typical for American and Iranian patients: Iranian patients are at higher risk for ocular vasculitis, but often present with single-organ disease. Conversely, American patients often have manifestations in multiple organ systems, but are less likely to develop ocular vasculitis. We propose that 1) several pathogenic pathways contribute to BD; 2) ocular and extra-ocular BD follow separable, possibly in Informed Consent: Written informed consent was obtained from the patients who participated in this study.
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